Skye Bioscience, Inc.
SKYE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,755 | -$17,625 | -$11,103 | -$9,746 |
| Dep. & Amort. | $179 | $187 | $177 | $175 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $2,202 | $2,089 |
| Change in WC | -$2,611 | $4,748 | -$461 | -$869 |
| Other Non-Cash | $1,823 | $1,944 | -$9,176,295 | $178 |
| Operating Cash Flow | -$13,364 | -$10,746 | -$9,185,480 | -$8,173 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$6,312 | -$50 |
| Net Acquisitions | $91 | $89 | $0 | -$1,218 |
| Inv. Purchases | $7,876 | -$11,944 | -$12,802,650 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $1,358 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $7,967 | -$11,855 | -$12,808,962 | $90 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $18 | $0 | -$83,557 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $83,562 |
| Financing Cash Flow | $0 | $18 | $0 | $6 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,397 | -$22,583 | -$21,994,442 | -$8,077 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,838 | $46,421 | $68,415,741 | $76,493 |
| End Cash | $18,441 | $23,838 | $46,421,299 | $68,416 |
| Free Cash Flow | -$13,364 | -$10,746 | -$9,191,792 | -$8,223 |